IDEXX Laboratories
Trade IDEXX Laboratories 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About IDXX
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other.
IDXX Key Statistics
Stock Snapshot
The current IDEXX Laboratories(IDXX) stock price is $643.21, with a market capitalization of 51.51B. The stock trades at a price-to-earnings (P/E) ratio of 49.28.
As of 2026-02-08, IDEXX Laboratories(IDXX) stock has fluctuated between $639.56 and $650.38. The current price stands at $643.21, placing the stock +0.6% above today's low and -1.1% off the high.
The IDEXX Laboratories(IDXX)'s current trading volume is 562.53K, compared to an average daily volume of 607.57K.
In the last year, IDEXX Laboratories(IDXX) shares hit a 52-week high of $769.98 and a 52-week low of $356.14.
In the last year, IDEXX Laboratories(IDXX) shares hit a 52-week high of $769.98 and a 52-week low of $356.14.
IDXX News
In early February 2026, IDEXX Laboratories reported past fourth-quarter and full-year 2025 results showing double-digit gains in revenue and earnings, alongside...
Barclays analyst Glen Santangelo lowered the firm’s price target on Idexx Laboratories (IDXX) to $800 from $850 and keeps an Overweight rating on the shares. Th...
IDEXX Laboratories (IDXX) is back in focus after reporting fourth quarter and full year 2025 results that topped analyst expectations, paired with fresh 2026 gu...
Analyst ratings
67%
of 18 ratingsMore IDXX News
IDEXX Laboratories Inc. (NASDAQ:IDXX) reported better-than-expected fourth-quarter financial results and issued a fiscal 2026 forecast on Monday. The animal he...
Erin Wright, an analyst from Morgan Stanley, maintained the Buy rating on Idexx Laboratories. The associated price target is $805.00. Claim 50% Off TipRanks Pre...
Idexx Laboratories ((IDXX)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium Unlock hedge fund-level d...
IDEXX Laboratories Inc. (NASDAQ:IDXX) on Monday reported better-than-expected fourth-quarter financial results and issued a fiscal 2026 forecast. The animal he...
Earnings Call Insights Idexx targets $4.632B–$4.720B revenue for 2026 as innovation drives 8%–10% CAG diagnostics growth Feb. 02, 2026 11:41 AM ET IDEXX Laborat...
(RTTNews) - While reporting financial results for the fourth quarter on Monday, pet healthcare provider IDEXX Laboratories, Inc. (IDXX) initiated its earnings a...
Reports Q4 revenue $1.09B, consensus $1.07B. “IDEXX delivered a strong finish to 2025, supported by consistently high levels of execution by IDEXX teams around...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.